KeyCorp director reports 1,574 deferred shares transaction in plan
KeyCorp director Todd J. Vasos reported equity holdings and a compensation-related share deferral.
Rhea-AI Filing Summary
KeyCorp director Todd J. Vasos reported equity holdings and a compensation-related share deferral. As of a transaction dated 12/31/2025, he held 35,255 KeyCorp common shares directly. In addition, he acquired 1,574 deferred shares under the Amended and Restated Directors' Deferred Share Sub-Plan to the KeyCorp Amended and Restated 2019 Equity Compensation Plan, at a reference price of $20.64 per deferred share.
The deferred shares are described as the economic equivalent of common shares, with payment deferred until the earlier of January 1, 2027 or the director's death. Following this transaction, Vasos held 65,087 derivative securities tied to common shares, which include approximately 630 dividend-equivalent deferred shares that accrued in December 2025.
Positive
- None.
Negative
- None.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Deferred Shares | 1,574 | $20.64 | $32K |
| holding | Common Shares | -- | -- | -- |
Footnotes (3)
- F1. Directors may elect to defer the payment of directors' fees into the Amended and Restated Directors' Deferred Share Sub-Plan to the KeyCorp Amended and Restated 2019 Equity Compensation Plan (the "Deferred Share Plan"). The deferred fees are converted into deferred shares, which are the economic equivalent of common shares.
- F2. Under the terms of the Deferred Share Plan, payment of the deferred shares has been deferred until the earlier of January 1, 2027, or the death of the participant.
- F3. Includes approximately 630 dividend-equivalent deferred shares accrued under the Deferred Share Plan in December 2025.
AI-generated analysis. How Rhea-AI works. Not financial advice.